David P Schenkein - Net Worth and Insider Trading

Over the past 18 months, David P Schenkein made no insider transaction in bluebird bio Inc (). Other recent insider transactions involving bluebird bio Inc () include a net sale of 33,313 shares made by Andrew Obenshain , a net sale of 10,485 shares made by Richard A Colvin , and a net sale of 12,339 shares made by Thomas J Klima .

In summary, during the past 3 months, insiders sold 27,248 shares of bluebird bio Inc () in total and bought 0 shares, with a net sale of 27,248 shares. During the past 18 months, 70,170 shares of bluebird bio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 70,170 shares.

bluebird bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David P Schenkein made no insider transaction in Denali Therapeutics Inc (). Other recent insider transactions involving Denali Therapeutics Inc () include a net sale of 106,621 shares made by Alexander O. Schuth , a net sale of 42,800 shares made by Carole Ho , and a net sale of 186,802 shares made by Ryan J. Watts .

In summary, during the past 3 months, insiders sold 136,870 shares of Denali Therapeutics Inc () in total and bought 0 shares, with a net sale of 136,870 shares. During the past 18 months, 500,892 shares of Denali Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 500,892 shares.

Denali Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David P Schenkein made 8 insider transaction in Agios Pharmaceuticals Inc () with a net sale of 205,692. Other recent insider transactions involving Agios Pharmaceuticals Inc () include a net sale of 8,791 shares made by Washburn Theodore James Jr. , a net sale of 14,160 shares made by James William Burns , and a net sale of 8,488 shares made by Sarah Gheuens .

In summary, during the past 3 months, insiders sold 118,772 shares of Agios Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 118,772 shares. During the past 18 months, 358,881 shares of Agios Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 358,881 shares.

Agios Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Foundation Medicine Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foundation Medicine Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foundation Medicine Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David P Schenkein made no insider transaction in Prime Medicine Inc (). Other recent insider transactions involving Prime Medicine Inc () include a net sale of 622,190 shares made by Gv 2019 Gp, L.l.c. , a net purchase of 4,000,000 shares made by Arch Venture Partners X, Llc , and a net purchase of 4,000,000 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc () in total and bought 9,600,000 shares, with a net purchase of 9,600,000 shares. During the past 18 months, 1,422,190 shares of Prime Medicine Inc () were sold and 12,400,000 shares were bought by its insiders, resulting in a net purchase of 10,977,810 shares.

Prime Medicine Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David P Schenkein made no insider transaction in Regeneron Pharmaceuticals Inc (). Other recent insider transactions involving Regeneron Pharmaceuticals Inc () include a net sale of 10,816 shares made by Marion Mccourt , a net sale of 1,300 shares made by Arthur F Ryan , and a net sale of 7,302 shares made by Bonnie L Bassler .

In summary, during the past 3 months, insiders sold 43,969 shares of Regeneron Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 43,969 shares. During the past 18 months, 198,549 shares of Regeneron Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 198,549 shares.

Regeneron Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.